Skip to main content
SpringerLink
Log in

Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure

  • Review Article
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

Abstract

A significant number of hypertensive subjects fail to achieve adequate blood pressure control despite adherence to maximal doses of several antihypertensive drugs. In the same way although medical and device therapies continue to improve the clinical course of heart failure patients, morbidity, mortality and healthcare costs remain high. Electrical stimulation of the carotid sinus is a new interesting approach for the treatment of resistant hypertension and heart failure. The purpose of this paper is to overview the argument starting from physiological background and evaluating the clinical results obtained with this approach in these pathophysiological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hering D, Kara T, Kucharska W, Somers VK, Narkiewicz K. High-normal blood pressure is associated with increased resting sympathetic activity but normal responses to stress tests. Blood Press. 2013;22:183–7.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724–8.

    Article  CAS  PubMed  Google Scholar 

  3. Grassi G, Seravalle G, Brambilla G, et al. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Int J Cardiol. 2014;177:1020–5.

    Article  PubMed  Google Scholar 

  4. Grassi G, Seravalle G, Mancia G. Left ventricular hypertrophy and sympathetic activity. Adv Exp Med Biol. 1997;432:173–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hansen J, Victor RG. Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens. 1994;3:636–43.

    Article  CAS  PubMed  Google Scholar 

  6. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.

    Article  CAS  PubMed  Google Scholar 

  7. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615–21.

    Article  CAS  PubMed  Google Scholar 

  8. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlöf G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913–9.

    Article  PubMed  Google Scholar 

  9. Grassi G, Seravalle G, Bertinieri G, et al. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci (Lond). 2001;101:141–6.

    Article  CAS  PubMed  Google Scholar 

  10. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–292.

    Article  PubMed  Google Scholar 

  11. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461–4.

    Article  CAS  PubMed  Google Scholar 

  12. Zanchetti A, Mancia G, Black HR, et al. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens. 2009;27:673–9.

    Article  CAS  PubMed  Google Scholar 

  13. Struijker-Boudier HA, Ambrosioni E, Holzgreve H, et al. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials? Int J Clin Pract. 2007;61:1592–602.

    Article  CAS  PubMed  Google Scholar 

  14. Waeber B, Volpe M, Ruilope LM, Schmieder RE. Diagnosis and treatment of resistant hypertension. Blood Press. 2014;23(4):193–9.

    Article  CAS  PubMed  Google Scholar 

  15. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–19.

    Article  CAS  PubMed  Google Scholar 

  16. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008;52:1749–57.

    Article  PubMed  Google Scholar 

  17. Chapman N, Dobson J, Wilson S, For the Anglo-Scandinavian Cardiac Outcomes Trial Investigators, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49:839–45.

    Article  CAS  PubMed  Google Scholar 

  18. Weber MA, Black H, Bakris G, et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomized double-blind placebo-blind placebo-controlled trial. Lancet. 2009;374:1423–31.

    Article  CAS  PubMed  Google Scholar 

  19. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.

    Article  PubMed  Google Scholar 

  20. Mohaupt MG, Schmidli J, Luft FC. Management of uncontrollable hypertension with a carotid sinus stimulation device. Hypertension. 2007;50:825–8.

    Article  CAS  PubMed  Google Scholar 

  21. Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55:619–26.

    Article  CAS  PubMed  Google Scholar 

  22. Burgoyne S, Georgakopoulos D, Belenkie I, Tyberg JV. Systemic vascular effects of acute electrical baroreflex stimulation. Am J Physiol Heart Circ Physiol. 2014;307:H236–41.

    Article  CAS  PubMed  Google Scholar 

  23. Bisognano JD, Bakris G, Nadim MK, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58:765–73.

    Article  PubMed  Google Scholar 

  24. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens. 2012;6:152–8.

    Article  PubMed  Google Scholar 

  25. Hoppe UC, Brandt MC, Wachter R, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 2012;6:270–6.

    Article  PubMed  Google Scholar 

  26. Brandt MC, Madershahian N, Velden R, Hoppe UC. Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clin Res Cardiol. 2011;100:249–51.

    Article  PubMed  Google Scholar 

  27. McCubbin JW, Green JH, Page IH. Baroreceptor function in chronic renal hypertension. Circ Res. 1956;4:205–10.

    Article  CAS  PubMed  Google Scholar 

  28. Werner HR. The frequency-dependent nature of blood pressure regulation by the carotid sinus studied with an electrical analog. Circ Res. 1958;6:35–40.

    Article  Google Scholar 

  29. Bilgutay A, Lillehei W. Treatment of hypertension with an implantable electronic device. JAMA. 1965;191:113–7.

    Article  Google Scholar 

  30. Schwartz S, Griffith L, Neistadt A, et al. Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg. 1967;114:5–15.

    Article  CAS  PubMed  Google Scholar 

  31. Tuckman J, Reich T, Lyon A, et al. Electrical stimulation of the sinus nerves in hypertensive patients-clinical evaluation and physiological studies. Hypertension. 1967;194S:23–38.

    Google Scholar 

  32. Peters T, Koralewski H, Zerbst F. Search for optimal frequencies and amplitudes of therapeutic electrical carotid sinus nerve stimulation by application of the evolutionary strategy. Artif Organs. 1989;13:133–43.

    Article  CAS  PubMed  Google Scholar 

  33. Peters T, Koralewski H, Zerbst F. The principle of electrical carotid sinus nerve stimulation: a nerve pacemaker system for angina pectoris and hypertension therapy. Ann Biomed Eng. 1980;8:445–58.

    Article  CAS  PubMed  Google Scholar 

  34. Wallin BG, Sundlof G, Delius W. The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch. 1975;358:101–10.

    Article  CAS  PubMed  Google Scholar 

  35. Parsonnet V, Myers GH, Holcomb WG, et al. Radio-frequency stimulation of the carotid baroreceptors in the treatment of hypertension. Surg Forum. 1966;17:125–7.

    CAS  PubMed  Google Scholar 

  36. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009;54:690–7.

    Article  CAS  PubMed  Google Scholar 

  37. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13:99S–105S.

    Article  CAS  PubMed  Google Scholar 

  38. Mancia G, Ludbrook J, Ferrari A, et al. Baroreceptor reflexes in human hypertension. Circ Res. 1978;43:170–7.

    Article  CAS  PubMed  Google Scholar 

  39. Lohmeier TE, Loheimer JR, Haque A, et al. Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1437–48.

    CAS  PubMed  Google Scholar 

  40. Lohmeier TE, Irwin E, Rossing M, et al. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension. 2004;4:306–11.

    Article  Google Scholar 

  41. Barrett CJ, Guild S, Ramchandra J, et al. Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension. 2005;46:1–5.

    Article  Google Scholar 

  42. Lohmeier TE, Dwyer TM, Irwin ED, et al. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension. 2007;49:1307–14.

    Article  CAS  PubMed  Google Scholar 

  43. Schmidli J, Mohaupt M, Savolainen H, et al. Response to acute electrical activation of the carotid baroreflex is maintained in drug refractory hypertension. J Hypertens. 2005;23(suppl 2):S6.

    Google Scholar 

  44. Schmidli J, Savolainen H, Eckstein F, et al. Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular. 2007;15:63–9.

    Article  PubMed  Google Scholar 

  45. Kroon A, Schmidli J, Scheffers I, et al. Chronically implanted system: 4-year data of Rheos DEBuT-HT Study in patients with resistant hypertension. J Hypertens. 2010;28(Suppl A):e441.

    Google Scholar 

  46. Scheffers I, Kroon AA, Schmidli J, et al. Novel baroreflex activation therapy in resistant hypertension: results of European Multicenter Feasibility Study. J Am Coll Cardiol. 2010;56:1254–8.

    Article  PubMed  Google Scholar 

  47. Scheffers I, Kroon AA, de Leeuw P. Renal hemodynamics during chronic therapy with electrical stimulation of the carotid sinus in humans. J Hypertens. 2008;26(suppl 1):S465.

    Google Scholar 

  48. Porter TR, Eckberg DL, Fritsch JM, et al. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest. 1990;85:1362–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206–11.

    Article  CAS  PubMed  Google Scholar 

  50. Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984;69:451–60.

    Article  CAS  PubMed  Google Scholar 

  51. Sabbah HN. Baroreflex activation for the treatment of heart failure. Curr Cardiol Rep. 2012;14:326–33.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Zucker IH, Hackley JF, Cornish KG, et al. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007;50:904–10.

    Article  CAS  PubMed  Google Scholar 

  53. Gronda E, Seravalle G, Brambilla G, et al. Chronic baroreflex activation effects on sympathetic nerve traffic, baro reflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail. 2014;16:977–83.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Cardiology Department, Ospedale San Luca, IRCCS Istituto Auxologico Italiano, Piazza Brescia 20, 20149, Milan, Italy

    Gino Seravalle

  2. Clinica Medica, Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy

    Guido Grassi

Authors
  1. Gino Seravalle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guido Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gino Seravalle.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seravalle, G., Grassi, G. Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure. High Blood Press Cardiovasc Prev 22, 233–239 (2015). https://doi.org/10.1007/s40292-015-0083-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40292-015-0083-6

Keywords

Search

Navigation